Table 3.
Plasma analyses in IC and GC groups.
|
IC (n = 37)
|
GC (n = 54)
|
|||
|---|---|---|---|---|
| Pre | Post | Pre | Post | |
| TC (mg/dL) | 213.6 ± 30.1 | 208.6 ± 32.0 | 210.8 ± 28.6 | 214.0 ± 36.8 |
| LDL-C (mg/dL) | 130.4 ± 27.5 | 122.5 ± 29.2* | 128.0 ± 26.7 | 132.2 ± 31.4 |
| HDL-C (mg/dL) | 49.2 ± 10.3 | 49.7 ± 11.2 | 49.9 ± 10.9 | 49.5 ± 11.0 |
| Triglycerides (mg/dL) | 183.4 ± 84.5 | 193.7 ± 141.2 | 191.6 ± 115.2 | 176.7 ± 112.7 |
| Plasma glucose (mg/dL) | 103.8 ± 15.6 | 104.5 ± 21.4 | 99.3 ± 11.6 | 105.1 ± 16.0 |
| Plasma insulin (μU/mL) | 7.5 ± 5.5 | 7.5 ± 6.3 | 5.9 ± 2.0 | 7.9 ± 4.9†,b |
| HOMA-IR | 1.93 ± 1.60 | 1.88 ± 1.52 | 1.45 ± 0.48a | 2.02 ± 1.16 |
| HbA1c (%) | 5.43 ± 0.58 | 5.36 ± 0.55* | 5.20 ± 0.48a | 5.27 ± 0.55 |
| AST (IU/l) | 26.4 ± 8.3 | 23.3 ± 5.9* | 34.7 ± 12.7a | 32.0 ± 11.2†,b |
| ALT (IU/l) | 32.8 ± 18.2 | 25.6 ± 11.1* | 47.4 ± 21.7a | 42.9 ± 21.8†,b |
| ALP (U/l) | 251.5 ± 64.4 | 251.9 ± 75.9 | 254.7 ± 85.8 | 247.2 ± 71.8 |
| GGT (IU/l) | 60.0 ± 38.6 | 50.2 ± 32.3* | 86.7 ± 79.5 | 77.5 ± 62.5†,b |
| Cholinesterase (IU/l) | 364.1 ± 61.7 | 343.6 ± 63.9* | 404.5 ± 73.9a | 387.2 ± 62.3†,b |
| hsCRP (mg/l) | 0.25 ± 0.67 | 0.28 ± 0.74 | 0.11 ± 0.17a | 0.12 ± 0.15 |
Notes: Values are the mean ± SD.
vs. pre-IC participants at P < 0.05;
vs. pre-GC participants at P < 0.05 (paired Student’s t-test).
vs. pre-IC participants at P < 0.05;
vs. post-IC participants at P < 0.05 (unpaired Student’s t-test).
Abbreviations: IC, individual counseling; GC, group counseling; Pre, at baseline; Post, after study; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-sensitivityß lipoprotein cholesterol; HOMA-IR, fasting plasma glucose (mg/dL) × fasting insulin (μU/mL)/405; HbA1c, glycosylated hemoglobin A1c; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; hsCRP, high-sensitivity C-reactive protein.